AtriCure, Inc. (ATRC)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $2.96B
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Latest financial period: June 30, 2026
Filed with the SEC: July 27, 2026
Estimated earnings date: November 4, 2026
Profit #1294 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | -0.3% | -2.5% | | -5.7% |
Growth #271 of 1484 companies
Payout #1117 of 1484 companies
Safety #402 of 1484 companies
Price #1241 of 1484 companies
